MRP2 and acquired tolerance to inorganic arsenic in the kidney of killifish (Fundulus heteroclitus)

Toxicological Sciences

Volumn 97, Issue 1, 2007, Pages 103-110

  Miller, David S ^a,b   Shaw, Joseph R ^b,c,d   Stanton, Caitlin R ^b,d   Barnaby, Roxanna ^d   Karlson, Katherine H ^d   Hamilton, Joshua W ^d   Stanton, Bruce A ^b,d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b MOUNT DESERT ISLAND BIOLOGICAL LABORATORY   (United States)

^c Dartmouth College   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Abcc2; Adaptation; Environmental toxicant; Xenobiotic transport

Indexed keywords

ABC TRANSPORTER; ARSENIC; ARSENITE SODIUM; GLUTATHIONE; INORGANIC COMPOUND; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; XENOBIOTIC AGENT; ARSENOUS ACID DERIVATIVE; CARRIER PROTEIN; DRUG DERIVATIVE; FLUORESCEIN DERIVATIVE; FLUORESCEIN METHOTREXATE; FLUORESCEIN-METHOTREXATE; FLUORESCENT DYE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; SODIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; CYPRINODONTIFORMES; ENVIRONMENTAL EXPOSURE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LONG TERM EXPOSURE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; ANIMAL; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; TISSUE DISTRIBUTION; UPREGULATION; WATER POLLUTANT;

CYPRINODONTOIDEI; FUNDULUS HETEROCLITUS;

ANIMALS; ARSENITES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FLUORESCEINS; FLUORESCENT DYES; FUNDULIDAE; KIDNEY TUBULES, PROXIMAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MITOCHONDRIA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; SODIUM COMPOUNDS; TISSUE DISTRIBUTION; UP-REGULATION; WATER POLLUTANTS, CHEMICAL;

EID: 34347222947     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm030     Document Type: Article

References (33)

1. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., et al. (1999). Arsenic: Health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107, 593-597.
2. Bears, H., Richards, J. G., and Schulte, P. M. (2006). Arsenic exposure alters hepatic arsenic species composition and stress-mediated gene expression in the common killifish (fundulus heteroclitus). Aquat. Toxicol. 77, 257-266.
3. Bodo, A., Bakos, E., Szeri, F., Varadi, A., and Sarkadi, B. (2003). The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett. 140-141, 133-143.
4. Boyle, R. W., Jonasson, I. R., National Research Council of Canada. Subcommittee on Metals and Canada, G. S. O. (1973). Geochemistry of Arsenic and Antimony. Geological Survey of Canada, Ottawa.
5. Gutmann, H., Miller, D. S., Droulle, A., Drewe, J., Fahr, A., and Fricker, G. (2000). P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. Br. J. Pharmacol. 129, 251-256.
6. Jones, B. R., Li, W., Cao, J., Hoffman, T. A., Gerk, P. M., and Vore, M. (2005). The role of protein synthesis and degradation in the post-transcriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2). Mol. Pharmacol. 68, 701-710.
7. Kala, S. V., Neely,M.W., Kala, G., Prater, C. I., Atwood, D.W., Rice, J. S., and Lieberman, M. W. (2000). The MRP2/cMOAT transporter and arsenicglutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275, 33404-33408.
8. Kendziorski, C. M., Zhang, Y., Lan, H., and Attie, A. D. (2003). The efficiency of pooling mRNA in microarray experiments. Biostatistics 4, 465-477.
9. Klaue, B., and Blum, J. D. (1999). Trace analyses of arsenic in drinking water by inductively coupled plasma mass spectrometry: High resolution versus hydride generation. Anal. Chem. 71, 1408-1414.
10. Lee, T. C., Ho, I. C., Lu,W. J., and Huang, J. D. (2006). Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. J. Biol. Chem. 281, 18401-18407.
11. Liu, J., Chen, H., Miller, D. S., Saavedra, J. E., Keefer, L. K., Johnson, D. R., Klaassen, C. D., and Waalkes, M. P. (2001). Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol. Pharmacol. 60, 302-309.
12. Masereeuw, R., Terlouw, S. A., van Aubel, R. A., Russel, F. G., and Miller, D. S. (2000). Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule. Mol. Pharmacol. 57, 59-67.
13. Meader, J. P., Ernest, D.W., and Kagley, A. (2004). Bioaccumulation of arsenic in marine fish and invertebrates from Alaska and California. Arch. Environ. Contam. Toxicol. 47, 223-233.
14. Miller, D. S., Graeff, C., Droulle, L., Fricker, S., and Fricker, G. (2002). Xenobiotic efflux pumps in isolated fish brain capillaries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R191-R198.
15. Moeller, A., MacNeil, S. D., Ambrose, R. F., and Que Hee, S. S. (2003). Elements in fish of Malibu Creek and Malibu Lagoon near Los Angeles, California. Mar. Pollut. Bull. 46, 424-429.
16. Neff, J. M. (1997). Ecotoxicology of arsenic in the marine environment - Review. Environ. Toxicol. Chem. 16, 917-927.
17. Notenboom, S., Miller, D. S., Kuik, L. H., Smits, P., Russel, F. G., and Masereeuw, R. (2005). Short-term exposure of renal proximal tubules to gentamicin increases long-term multidrug resistance protein 2 (Abcc2) transport function and reduces nephrotoxicant sensitivity. J. Pharmacol. Exp. Ther. 315, 912-920.
18. Notenboom, S., Miller, D. S., Smits, P., Russel, F. G., and Masereeuw, R. (2004). Involvement of guanylyl cyclase and cGMP in the regulation of Mrp2-mediated transport in the proximal tubule. Am. J. Physiol. Renal Physiol. 287, F33-F38.
19. Notenboom, S.,Wouterse, A. C., Peters, B., Kuik, L. H., Heemskerk, S., Russel, F. G., and Masereeuw, R. (2006). Increased apical insertion of the multidrug resistance protein 2 (MRP2/ABCC2) in renal proximal tubules following gentamicin exposure. J. Pharmacol. Exp. Ther. 318, 1194-1202.
20. Peraza, M. A., Carter, D. E., and Gandolfi, A. J. (2003). Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol. Toxicol. 19, 253-264.
21. Peraza, M. A., Cromey, D. W., Carolus, B., Carter, D. E., and Gandolfi, A. J. (2006). Morphological and functional alterations in human proximal tubular cell line induced by low level inorganic arsenic: Evidence for targeting of mitochondria and initiated apoptosis. J. Appl. Toxicol. 26, 356-367.
22. Pritchard, J. B., and Miller, D. S. (1980). Teleost kidney in evaluation of xenobiotic toxicity and elimination. Fed. Proc. 39, 3207-3212.
23. Robertson, E. E., and Rankin, G. O. (2006). Human renal organic anion transporters: Characteristics and contributions to drug and drug metabolite excretion. Pharmacol. Ther. 109, 399-412.
24. Rosen, B. P. (2002). Biochemistry of arsenic detoxification. FEBS Lett. 529, 86-92.
25. Shaw, J. R., Gabor, K., Hand, E., Lankowski, A., Durant, L., Thibodeau, R., Stanton, C. R., Barnaby, R., Coutermarsh, B., Karlson, K. H., et al. (2007). Role of glucocorticoid receptor in acclimation of killifish (Fundulus heteroclitus) to seawater and effects of arsenic. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R1052-R1060.
26. Stanton, C. R., Thibodeau, R., Lankowski, A., Shaw, J. R., Hamilton, J.W., and Stanton, B. A. (2006). Arsenic inhibits CFTR-mediated chloride secretion by killifish (Fundulus heteroclitus) opercular membrane. Cell. Physiol. Biochem. 17, 269-278.
27. Terlouw, S. A., Graeff, C., Smeets, P. H., Fricker, G., Russel, F. G.,Masereeuw, R., and Miller, D. S. (2002). Short- and long-term influences of heavy metals on anionic drug efflux from renal proximal tubule. J. Pharmacol. Exp. Ther. 301, 578-585.
28. Terlouw, S. A., Masereeuw, R., and Russel, F. G. (2003). Modulatory effects of hormones, drugs, and toxic events on renal organic anion transport. Biochem. Pharmacol. 65, 1393-1405.
29. Terlouw, S. A., Masereeuw, R., Russel, F. G., and Miller, D. S. (2001). Nephrotoxicants induce endothelin release and signaling in renal proximal tubules: Effect on drug efflux. Mol. Pharmacol. 59, 1433-1440.
30. Trauner, M., Arrese, M., Soroka, C. J., Ananthanarayanan, M., Koeppel, T. A., Schlosser, S. F., Suchy, F. J., Keppler, D., and Boyer, J. L. (1997). The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113, 255-264.
31. van Aubel, R. A., van Kuijck, M. A., Koenderink, J. B., Deen, P. M., van Os, C. H., and Russel, F. G. (1998). Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol. Pharmacol. 53, 1062-1067.
32. Vernhet, L., Seite, M. P., Allain, N., Guillouzo, A., and Fardel, O. (2001). Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes. J. Pharmacol. Exp. Ther. 298, 234-239.
33. Wever, K. E., Masereeuw, R., Miller, D. S., Hang, X. M., and Flik, G. (2007). Endothelin and calciotropic hormones share regulatory pathways in multidrug resistance protein 2 (Mrp2) mediated transport. Am. J. Physiol. Renal Physiol. 292, F38-F46.